RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/16007223http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/16007223http://www.w3.org/2000/01/rdf-schema#comment"Neurofibromatosis type 2 (NF2) is the most commonly mutated gene in benign tumors of the human nervous system such as schwannomas and meningiomas. The NF2 gene encodes a protein called schwannomin or merlin, which is involved in regulating cell growth and proliferation through protein-protein interactions with various cellular proteins. In order to better understand the mechanism by which merlin exerts its function, yeast two-hybrid screening was performed and Ral guanine nucleotide dissociation stimulator (RalGDS), a downstream molecule of Ras, was identified as a merlin-binding protein. The direct interaction between merlin and RalGDS was confirmed both in vitro and in the NIH3T3 cells. The domain analyses revealed that the broad C-terminal region of merlin (aa 141-595) is necessary for the interaction with the C-terminal Ras-binding domain (RBD) of RalGDS. Functional studies showed that merlin inhibits the RalGDS-induced RalA activation, the colony formation and the cell migration in mammalian cells. These results suggest that merlin can function as a tumor suppressor by inhibiting the RalGDS-mediated oncogenic signals."xsd:string
http://purl.uniprot.org/citations/16007223http://purl.org/dc/terms/identifier"doi:10.1038/sj.onc.1208633"xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/author"Kim H."xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/author"Kim Y.H."xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/author"Lee K.H."xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/author"Lee J.Y."xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/author"Lee W.K."xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/author"Kim S.W."xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/author"Choi B.H."xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/author"Lim Y."xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/author"Ryu C.H."xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/author"Rha H.K."xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/author"Hwang T.K."xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/author"Jun T.Y."xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/author"Lee K.H.'"xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/date"2005"xsd:gYear
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/name"Oncogene"xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/pages"5355-5364"xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/title"The merlin tumor suppressor interacts with Ral guanine nucleotide dissociation stimulator and inhibits its activity."xsd:string
http://purl.uniprot.org/citations/16007223http://purl.uniprot.org/core/volume"24"xsd:string
http://purl.uniprot.org/citations/16007223http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/16007223
http://purl.uniprot.org/citations/16007223http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/16007223
http://purl.uniprot.org/uniprot/#_B3KPK6-mappedCitation-16007223http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16007223
http://purl.uniprot.org/uniprot/#_Q12967-mappedCitation-16007223http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16007223